← Leaderboards
Wilfred Ngwa
Dana-Farber Cancer Inst
$5,702,695
Attributed
$6,788,389
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,788,389 · 8
By mechanism
R01$3,236,883 · 1
R42$1,398,461 · 2
K01$882,913 · 1
R21$420,856 · 1
U54$409,276 · 1
R41$400,000 · 1
Top collaborators
- Adam Shilling3 shared
- Stephen Avery2 shared
- Akila Viswanathan1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Yiwen Chen$5,075,628
- Timothy R Rebbeck$50,819,475
- Akila Viswanathan$4,487,501
Others in their field
Top investigators on “Radiation Therapy”
- Philip J Disaia · University Of California Irvine$132,438,187
- Walter John Curran · Thomas Jefferson University$132,004,598
- Richard L Schilsky · University Of Chicago$123,524,424
- Norman Wolmark · Nsabp Foundation, Inc.$104,937,424
- Monica M Bertagnolli · Strang Cancer Prevention Center$66,963,796
- Charles A Coltman · Southwest Oncology Group$64,545,998
Research focus
Radiation TherapyMalignant NeoplasmsDesignCancer PatientTumorNeoplasm MetastasisToxic EffectInnovationNanoparticleQuality Of LifeIn SituBiodistributionBiocompatible MaterialsImmunotherapyPolymersTechnologyPhotonsImplantSafetyEnsureTreatment EfficacyCollaborationsDoseCancer Care
Grant awards (21)
Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical Cancer$998,781
R42 · FY2025 · CA
Project 2$205,036
U54 · FY2025 · CA · contact PI
Project 2$204,240
U54 · FY2024 · CA · contact PI
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy$584,931
R01 · FY2023 · CA · contact PI
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy$584,931
R01 · FY2022 · CA · contact PI
Liquid Immunogenic Fiducial Eluter (LIFE) for Cervical Cancer Treatment$400,000
R41 · FY2022 · CA
Radio-immunotherapy dose-painting (RAID) treatment for hormonal resistant prostate cancer$399,680
R42 · FY2022 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy$199,909
R01 · FY2022 · CA · contact PI
Global Health Catalyst (GHC) Summit$20,000
R13 · FY2022 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy$390,321
R01 · FY2021 · CA · contact PI
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy$211,789
R01 · FY2021 · CA · contact PI
Global Health Catalyst (GHC) Summit$20,000
R13 · FY2021 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy$632,501
R01 · FY2020 · CA · contact PI
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy$632,501
R01 · FY2019 · CA · contact PI
Primers: Combining Radiotherapy and Immunotherapy using next genertaion radiotherapy biomaterials$191,669
R21 · FY2018 · CA · contact PI
Primers: Combining Radiotherapy and Immunotherapy using next genertaion radiotherapy biomaterials$229,187
R21 · FY2017 · CA · contact PI
Brachytherapy in situ dose-painting administered via gold-nanoparticle eluters$177,120
K01 · FY2017 · CA · contact PI
Brachytherapy in situ dose-painting administered via gold-nanoparticle eluters$176,769
K01 · FY2016 · CA · contact PI
Brachytherapy in situ dose-painting administered via gold-nanoparticle eluters$176,476
K01 · FY2015 · CA · contact PI
Brachytherapy in situ dose-painting administered via gold-nanoparticle eluters$176,435
K01 · FY2014 · CA · contact PI
Brachytherapy in situ dose-painting administered via gold-nanoparticle eluters$176,113
K01 · FY2013 · CA · contact PI